Arizona Tribune - Boulevard

NYSE - LSE

CMSC	-0.84%	21.102	$
RBGPF	0%	68.56	$
BCC	0.85%	82.47	$
RIO	2.97%	105.3	$
JRI	-0.24%	12.38	$
BTI	-0.87%	56.21	$
BCE	-0.3%	23.71	$
CMSD	-0.67%	20.98	$
GSK	0.86%	52.41	$
NGG	-1.08%	79.76	$
RELX	1.48%	35.91	$
AZN	0.9%	165.98	$
VOD	-0.31%	15.96	$
BP	-0.85%	44.76	$
RYCEF	-1.23%	20.25	$

Featured

Pope visits San Marino, before addressing Italian political gathering

Pope Leo XIV arrived Saturday in the tiny republic of San Marino ahead of an address to a cultural and political event organised by an influential Catholic group at the Italian seaside resort of Rimini.

At least 2 teens seriously wounded in sword attack at Swedish school

At least two teenagers were seriously wounded after a sword-wielding attacker entered a high school in central Sweden, authorities said, while media reported the perpetrator had been shot by police.

Last news

Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders

TORONTO, ON / ACCESS Newswire / June 17, 2026 / Polaris Renewable Energy Inc. (the "Corporation" or "Polaris") today announced that its annual meeting of shareholders (the "Meeting"), originally scheduled to be held on June 18, 2026 at 9:00 a.m. (Toronto time), has been postponed.

TRNR Updates FAQs, With a More Than 50% Quarterly Revenue Increase Expected in Q2 From Q1

Company Addresses Q2 and FY 2026 expectations, Run-rate profitability by year-end, Additional Potential Acquisitions and Results of Annual Meeting

Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean

IRVINE, CA / ACCESS Newswire / June 17, 2026 / Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) is pleased to announce that it has entered into a formal agreement for its drug treatments for prostate conditions, with the Global Alliance of Regenerative Medicine (GARM) on Roatan Island in the Western Caribbean. Nymox's Nymozarfex (TM) which is owned and developed by Nymox, will be offered and available to men to improve their prostate health and to treat prostate disease. GARM is a leader in the field of providing the most innovative therapies in personalized treatments and wellness care. GARM for over 12 years has successfully brought to patients advanced treatments that are not currently available in traditional care facilities. Nymozarfex (TM) will now be available to the public, to men who need a better way to treat their enlarged prostate and to improve their prostate health. GARM will be offering Nymozarfex (TM) to the public, fully licensed in Roatan. Nymozarfex will be provided by certified expert urologists with GARM, in their state of the art medical facility on beautiful Roatan Island.

Keena Healthcare Technology Transitions to Employee Ownership Through ESOP

Founders Steve Buttitta and Craig Luce transfer full company ownership to employees, marking a milestone in Keena's 20-year legacy of healthcare IT innovation

The PIPEs Conference Returns to the Hard Rock Hotel & Casino in Hollywood, Fla Nov. 4-5

HOLLYWOOD, FL / ACCESS Newswire / June 17, 2026 / The PIPEs Conference is back - and the market's most active players will be in the room November 4-5, 2026. Join investors, public company executives, investment bankers, legal advisors, and capital markets professionals at the annual event dedicated exclusively to Private Investments in Public Equity.

Viola Chan to Launch Couture Bridal Collection Exclusively for Kleinfeld

Globally Acclaimed Designer and David's Bridal Head of Couture & Design Debuts an Exclusive Collection Created for Today's Modern Brides; Will Host Designer Trunk Show August 27-30 at Kleinfeld

GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand

More People Than Ever Taking GLP-1 Drugs for Weight LossGrowing List of Diseases Now Indicated as Treatable With GLP-1 Drugs

Snapshot Recipes AI Turns Refrigerator Photos Into Personalized Recipes From Virtually Any Cuisine

Medical Care Technologies (OTC PINK: MDCE) accelerates social media expansion and user engagement initiatives.

Smart Money Media Expands AEO and GEO Practice as AI Search Reshapes How Brands are Discovered

Smart Money Media Combines Tier-One Earned Editorial With Answer Engine and Generative Engine Optimization to Help Brands Get Cited Inside AI Assistants

MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy

Randomized, double-blind, placebo-controlled study to evaluate safety, tolerability, and dose-response efficacy of oral Ketamir-2 at a leading U.S. cancer center

Moderna to Host Investor Event - Science Day

CAMBRIDGE, MA / ACCESS Newswire / June 17, 2026 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Science Day at 9:00am ET on Thursday, June 25, 2026.

Global Stem Cells Group (OTC:RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for Regenerative Medicine

New physician-facing platform digitizes a 30+ country network and lays the foundation for ISSCA AI™, positioning RMTG at the intersection of regenerative medicine and scalable health technology

CTT Pharma Signs LOI with European Company

TAMPA, FL / ACCESS Newswire / June 17, 2026 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed an LOI with a company in the United States to conduct clinical trials and testing for several potential nicotine products for CTT Pharma. A partnership with this company would allow CTT the ability to independently go to market in the United States utilizing our patented technology. CTT Pharma will notify shareholders as more information becomes available.

InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 17

LONDON, UK / ACCESS Newswire / June 17, 2026 / The Company announces that on 16 June 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.

Genflow Biosciences PLC - Company to present at Animal Longevity Summit 2026

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Former DEA Section Chief Steps Forward to Challenge Marijuana Rescheduling Process

"As DEA Prepares for June 29 Hearing, MMJ International Holdings Brings Forward the Very Experts Who Built, Enforced, and Understand the Federal Drug Approval System" stated Duane Boise CEO MMJ International Holdings.

EU admits it can't save discontinued video games

It's game over for fans of discontinued video games after the EU admitted defeat on Tuesday and said it cannot stop publishers making them unplayable.

India braces for El Nino-linked dry conditions

India will prepare contingency plans to help farmers weather potential low rainfall linked to the El Nino weather system, agriculture officials said Tuesday.

Restoring Kyiv cathedral hit by Russia could take two years: director

It could take around two years to repair Kyiv's Dormition Cathedral and its surrounding monastery complex after they were damaged in a Russian attack, its director said Tuesday.

Vast areas of coral reef could resist climate change: study

In the crystalline waters off Kenya's coast, coral reefs are thriving -- evidence of a rare good news story in the battle to protect oceans from the ravages of climate change.

INEO Tech Corp. Announces Closing of Private Placement and Debt Settlement

SURREY, BC / ACCESS Newswire / June 16, 2026 / INEO Tech Corp. (TSXV:INEO)(OTCQB:INEOF, currently trading as INEOD until early July 2026 due to the recent share consolidation) (the "Company" or "INEO") announces that further to its news releases dated May 4, 2026, and May 28, 2026, the Company closed its previously announced non-brokered private placement of Shares (the "Share Offering"), issuing 15,000,000 Shares, at a price of $0.10 per Share for gross proceeds of $1,500,000.

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

VANCOUVER, BC / ACCESS Newswire / June 16, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news release dated November 18, 2025, the completion of its pilot project with Kuano Ltd. ("Kuano"), supporting the continued advancement of Onco's PNKP Inhibitor Technology (also known as ONC010) through advanced AI-enabled and quantum-based computational approaches.

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results

Revenues increased 48% in Q4 2026 compared to Q4 2025, and 37% in FY 2026 compared to FY 2025United States revenues increased 194% in Q4 2026 compared to Q4 2025 and 117% in FY 2026 compared to FY 2025Net loss improved 25% in Q4 2026 compared to Q4 2025, and 8% in FY 2026 compared to FY 2025EBITDA loss improved 66% in Q4 2026 compared to Q4 2025, and 38% in FY 2026 compared to FY 2025

Protagonist Therapeutics Reports Granting of Inducement Awards

NEWARK, CA / ACCESS Newswire / June 16, 2026 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on June 15, 2026, it granted inducement awards to three recently hired employees in accordance with the terms of their employment offer letters. The awards were granted under the Protagonist Therapeutics Amended and Restated Inducement Plan, which was adopted May 29, 2018, and amended February 18, 2020 and February 15, 2022.

Nickelodeon 90's Mash-up Candle Collection Launches Exclusively at GooseCreek.com

LIBERTY, KY / ACCESS Newswire / June 16, 2026 / Goose Creek is bringing the ultimate throwback experience home with the launch of its new Nickelodeon 90's Mash-up Candle Collection, inspired by the unforgettable shows, characters, colors, and chaos that defined an entire generation of television fans.

Jeffery Miglicco Co-Authors Amazon Best-Selling Leadership Book with Chris Voss

Jeffery Miglicco joins national best-selling author status with former FBI hostage negotiator Chris Voss in a new business book exploring empathy, accountability, and leadership performance.

On Sale Now! LiberNovo Maxis Big & Tall Ergonomic Chair Debuts, Unlocking a New Level of "Stability, Width, and Comfort" for Prolonged Sitting

The Maxis series is live today across the US, Canada, and Europe, starting at US$809, with launch savings up to 44% off MSRP.

HonorBridge Names Joel Baucom Chief Operating Officer

CHAPEL HILL, NC / ACCESS Newswire / June 16, 2026 / HonorBridge is pleased to announce that Joel Baucom, M.Div., has been named Chief Operating Officer. Baucom brings 15 years of experience at HonorBridge to the role, having served in a variety of positions across the organization, including Family Support Coordinator, Manager of Family Services, Director of Organ Operations and Director of Partner Engagement.

Medical Care Technologies (OTC PINK:MDCE) Discusses Enterprise-Grade Privacy Architecture for MDCE Melanoma Scan Beta

Company discusses secure image handling, privacy-focused platform architecture, and future compliance-oriented development initiatives

Barefoot Risks: Why Summer Activities Can Lead to Hidden Foot Injuries, According to Ankle & Foot Centers of America

ATLANTA, GA / ACCESS Newswire / June 16, 2026 / As temperatures rise and more people spend time outdoors, Ankle & Foot Centers of America is encouraging individuals to be mindful of the hidden risks that summer activities can pose to foot health.

MIB Agents' Community of Families Has Awarded $2.9M in Grants to Research Pediatric Bone Cancer

Leading Pediatric Osteosarcoma Nonprofit to Present $400,000 to 5 Scientists During Annual Conference to Find Kinder Treatments for Patients

Dolphin Subsidiary 42West's 25th Tribeca Film Festival Slate Delivered a Standout Film Slate Featuring 16 Film and TV Titles

Activities Included Appearances by Clients Martin Scorsese, Rebecca Miller, Marc Maron; Films by Sean Ono Lennon, Andrew Neel, Sam Pollard, Sophia Takal; World Premiere of Prime Video Series 'Every Year After,' and Much More

Arizona Tribune - Boulevard (English)